🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

American Well Corp announces 1-for-20 reverse stock split

EditorAhmed Abdulazez Abdulkadir
Published 16/07/2024, 13:00
AMWL
-

Boston-based American Well Corporation, known for its telehealth solutions, has announced a reverse stock split of its shares at a 1-for-20 ratio. This corporate action took effect after the market closed on July 10, 2024, and the company's Class A common stock commenced trading on a split-adjusted basis from the next trading day.

The reverse stock split also applies to the company's Class B and Class C common stock. Following the split, the trading symbol for American Well's Class A common stock remains "AMWL" on the New York Stock Exchange. Additionally, the CUSIP number, an identifier used to record and track securities, has changed to 03044L 204 post-split.

This strategic move is detailed in a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, which was filed with the Secretary of State of the State of Delaware.

The reverse stock split is a mechanism often used by companies to boost their stock price by reducing the number of shares outstanding, which can potentially lead to increased interest from investors who may perceive the higher price as a sign of value.

In other recent news, American Well Corp., also known as Amwell, disclosed the results of its annual shareholder meeting, where key proposals were approved, including the election of directors, ratification of the company's independent auditor, executive compensation, and a reverse stock split.

In terms of financial performance, Amwell reported a 7% decline in total revenue to $59.5 million for the first quarter of 2024, but anticipates a shift towards subscription software expected to drive gross margin expansion. The company also forecasts revenue growth and improved adjusted EBITDA for 2025.

On the leadership front, Co-founder Roy Schoenberg will transition from his dual role as president and co-CEO to become the Executive Vice Chairman of the company's Board of Directors, with Ido Schoenberg taking over as the sole Chief Executive Officer.

Piper Sandler, an investment firm, maintained a neutral stance on Amwell, emphasizing the need for stabilization in subscription revenue and clearer signs of the company's projected return to double-digit growth in 2025.

InvestingPro Insights

In the wake of American Well Corporation's recent reverse stock split, a closer look at the company's financial health and market performance may provide investors with a clearer picture. According to InvestingPro data, American Well holds a market capitalization of $111.42 million. Despite the reverse stock split's intention to enhance stock appeal, the company's valuation metrics reveal challenges, with a negative P/E ratio of -0.3 and a decline in revenue growth of -8.08% over the last twelve months as of Q1 2024.

InvestingPro Tips suggest a mixed outlook for American Well. On the positive side, the company holds more cash than debt on its balance sheet and has liquid assets exceeding short-term obligations, indicating a degree of financial stability. Additionally, two analysts have revised their earnings upwards for the upcoming period, offering a glimmer of potential optimism. However, the company is not expected to be profitable this year, and its valuation implies a poor free cash flow yield. Furthermore, the stock has experienced significant volatility, with a notable return over the last week but a substantial price decline over the past year.

For investors seeking more in-depth analysis, there are additional InvestingPro Tips available at https://www.investing.com/pro/AMWL that could further inform their decisions. To access these insights, consider using the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.